August 25, 2021 -- ConcertAI has expanded its multiyear collaboration with Janssen Research and Development to develop new therapies while addressing health disparities in clinical trials.
The partnership aims to develop more effective treatments for patients using ConcertAI's oncology real-world data and artificial intelligence (AI). Through the partnership, ConcertAI will broaden the sources of data used, moving earlier into disease states and assuring that more patients have access to therapies both through clinical trials and through enhanced evidence generation.
Already have an account? Sign in Here
To access all ScienceBoard content create a free account now: